[Analysis of a therapeutic failure of L-Dopa: can Adams-Van Bosaert and Van Der Eecken's strio-nigral degeneration be diagnosed during the patient's life?].
D000368:Aged; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D003342:Corpus Striatum / Q000503:physiopathology; D003711:Demyelinating Diseases / Q000150:complications / Q000175:diagnosis*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D010302:Parkinson Disease, Secondary / Q000188:drug therapy* / Q000209:etiology; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D012701:Serotonin / Q000134:cerebrospinal fluid / Q000652:urine; D013378:Substantia Nigra / Q000503:physiopathology
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D010648:Phenylacetates; D012701:Serotonin; D007980:Levodopa
Analyse d'un échec thérapeutique de la L-Dopa: La dégénérescence strio-nigrique d'Adams-Van Bogaert et Van Der Eecken peut-elle être diagnostiquée du vivant des malades?